ISPOR Ireland published analysis in September 2026 drawing on data from the post-FASPM 2026–2029 Framework Agreement period. The data indicated that the average time to reimbursement from EMA approval had improved from 705 days (2023) to 623 days (2025).1 The Central Pricing Unit (CPU) of the HSE reported its average turnaround time for pricing applications […]
The All Wales Medicines Strategy Group published its Annual Report for 2025–26 on 7 September 2026.1 The report records that 76 medicines were subject to AWMSG appraisal in the year. NHS Wales follows NICE technology appraisals automatically, with a 60-day funding obligation rather than the 90-day standard applying in England. Blueteq comment: AWTTC (the All […]
Unit A5, Endeavour Business Park
Penner Road, Havant
PO9 1QN
Company Registration Number: 5334133
Company VAT Number: 855 7246 95
© 2026 Blueteq Ltd
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.